How AIM shell can grow by 1,000% Collagen Solutions’ (COS)
second reverse transaction in the table because it provides an interesting comparison to the original reversal into Healthcare Investment Opportunities in January. The share price fell back after the...
View ArticleWhat Is Collagen Actually Used For?
Companies like Collagen Solutions PLC LON:COS will be well used to hearing the various myths and tales about beneficial applications of collagen that are sometimes far fetched and somewhat distant from...
View ArticleCollagen Solutions plc benefits heart surgery patients with new “patent granted”
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics,has told DirectorsTalk...
View ArticleCollagen Solutions Plc New Patent leads way to Licensing Avenues
Collagen Solutions PLC LON:COS the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has this morning announced...
View ArticlePanmure Gordon Remain buyers of Collagen Solutions : US Patent granted
Panmure Gordon analyst Dr Mike Mitchell said this morning; “This morning, Collagen Solutions has announced that the US Patent Office has granted a US patent for the processing of a new bio-material...
View ArticleBiomaterial – Collagen Solutions Plc, Global Heart Valve Repair and...
// // New Patent Granted Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro...
View ArticleCollagen Solutions gets US patent approval Herald Scotland
A SUBSIDIARY of Collagen Solutions has secured a patent in the United States for the processing of a new biomaterial which can be used in heart valve replacements. The AIM-listed company said Southern...
View ArticleCollagen Solutions CEO Stewart White interview on New Patent
Collagen Solutions plc LON:COS CEO Stewart White chats with DirectorsTalk about the granting of a new patent for the processing of a new bio-material which will provide benefits for heart surgery...
View ArticleInterview: Q and A with Stewart White Chief Executive Officer of Collagen...
Collagen Solutions plc (LON:COS) Chief Executive Officer Stewart White caught up with DirectorsTalk for an exclusive interview to discuss the granting of a new patent in the US to Southern Lights...
View ArticleThe chief executive of Collagen Solutions, Stewart White, speaks
Collagen develops and manufactures medical-grade collagen components used in regenerative medicine, and medical devices ranging from hemostats and surgical meshes. It is looking to build itself into a...
View ArticleClik here to view.
Collagen Solutions aiming to become a £100mln company
Collagen Solutions has set itself the goal of becoming a £100mln company in the next five years. Most commonly found in the skin, collagen is the structural protein that supports various connective...
View ArticleCollagen Solutions plc “Innovate UK Grant award”
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has told...
View ArticleCollagen Solutions wins Innovate grant Herald Scotland
COLLAGEN Solutions has received a grant from Innovate UK to develop a novel material which could be used to help heal internal wounds more quickly. The AIM-listed firm, which has its main UK...
View ArticleClik here to view.
Collagen Solutions plc Update by Hardman & Co
Regenerative medicine partnership You can download the full report free by Hardman & Co here: Collagen Solutions – Update – 22 June 2015 Collagen Solutions plc LON:COS announced that, together...
View ArticleCollagen Solutions hires Panmure as Nomad Herald Scotland
BIOMATERIALS manufacturer Collagen Solutions has appointed Panmure Gordon as its sole broker and nominated adviser (Nomad). The company has also granted Panmure warrants to subscribe for more than 1.7...
View ArticleClik here to view.
SMALL SHARE IDEAS: Collagen Solutions aims for £100milllion market cap by...
Collectively the markets it operates in are worth around £10billion annually – which makes its target of becoming a £100milllion market cap business by 2020 achievable.
View ArticleCollagen Solutions plc final results with increased revenue
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has given...
View ArticlePanmure Gordon thoughts on Collagen Solutions this morning
Panmure Gordon Analyst Dr Mike Mitchell said this morning on Collagen Solutions: “Prelim results have delivered a performance in-line with our expectations. The company reports revenue and other income...
View ArticleCollagen Solutions CEO Stewart White Interview on Final Results
Collagen Solutions Plc LON:COS CEO Stewart White discusses the release of it’s Final Results for Year End Mar 31 2015. Dr Stewart White was CEO of Collbio and has recent and direct board experience...
View Article
